Targeting liver X receptors in inflammation

Bibliography

• Apfel R, Benbrook D, Lernhardt E, et al. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol 1994;14:7025-35
   PubMed Web of Science ®Google Scholar
• Teboul M, Enmark E, Li Q, et al. OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor. Proc Natl Acad Sci USA 1995;92:2096-100
   PubMed Web of Science ®Google Scholar
• Janowski BA, Willy PJ, Devi TR, et al. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996;383:728-31
   PubMed Web of Science ®Google Scholar
• Lehmann JM, Kliewer SA, Moore LB, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997;272:3137-40
   PubMed Web of Science ®Google Scholar
• Viennois E, Mouzat K, Dufour J, et al. Selective liver X receptor modulators (SLiMs): what use in human health? Mol Cell Endocrinol 2012;351:129-41
   PubMed Web of Science ®Google Scholar
• Repa JJ, Turley SD, Lobaccaro JA, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2000;289:1524-9
   PubMed Web of Science ®Google Scholar
• Collins JL, Fivush AM, Watson MA, et al. Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 2002;45:1963-6
   PubMed Web of Science ®Google Scholar
• Zuercher WJ, Buckholz RG, Campobasso N, et al. Discovery of tertiary sulfonamides as potent liver X receptor antagonists. J Med Chem 2010;53:3412-16
   PubMed Web of Science ®Google Scholar
• Hu B, Unwalla RJ, Goljer I, et al. Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist. J Med Chem 2010;53:3296-304
   PubMed Web of Science ®Google Scholar
• Yasuda T, Grillot D, Billheimer JT. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol 2010;30:781-6
   PubMed Web of Science ®Google Scholar
• Hu B, Jetter J, Kaufman D, et al. Further modification on phenyl acetic acid based quinolines as liver X receptor modulators. Bioorg Med Chem 2007;15:3321-33
   PubMedGoogle Scholar
• Chao EY, Caravella JA, Watson MA, et al. Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity. J Med Chem 2008;51:5758-65
   PubMed Web of Science ®Google Scholar
• Griffett K, Solt LA, El-Gendy Bel D, et al. A liver-selective LXR inverse agonist that suppresses hepatic steatosis. ACS Chem Biol 2013;8:559-67
   PubMed Web of Science ®Google Scholar
• Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 2006;116:607-14
   PubMed Web of Science ®Google Scholar
• Farnegardh M, Bonn T, Sun S, et al. The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands. J Biol Chem 2003;278:38821-8
   PubMed Web of Science ®Google Scholar
• Svensson S, Ostberg T, Jacobsson M, et al. Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. Embo J 2003;22:4625-33
   PubMed Web of Science ®Google Scholar
• Wagner BL, Valledor AF, Shao G, et al. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol 2003;23:5780-9
   PubMed Web of Science ®Google Scholar
• Jakobsson T, Venteclef N, Toresson G, et al. GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. Mol Cell 2009;34:510-18
   PubMedGoogle Scholar
• Boergesen M, Pedersen TA, Gross B, et al. Genome-wide profiling of LXR, RXR and PPARalpha in mouse liver reveals extensive sharing of binding sites. Mol Cell Biol 2012;32:852-67
   PubMed Web of Science ®Google Scholar
• Pehkonen P, Welter-Stahl L, Diwo J, et al. Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages. BMC Genomics 2012;13:50
   PubMed Web of Science ®Google Scholar
• Heinz S, Benner C, Spann N, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010;38:576-89
   PubMed Web of Science ®Google Scholar
• Li X, Zhang S, Blander G, et al. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 2007;28:91-106
   PubMed Web of Science ®Google Scholar
• Kim KH, Yoon JM, Choi AH, et al. Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1. Mol Endocrinol 2009;23:466-74
   PubMedGoogle Scholar
• Chen M, Bradley MN, Beaven SW, et al. Phosphorylation of the liver X receptors. FEBS Lett 2006;580:4835-41
   PubMedGoogle Scholar
• Torra IP, Ismaili N, Feig JE, et al. Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages. Mol Cell Biol 2008;28:2626-36
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Shimano H, Inoue N, et al. Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J Biol Chem 2007;282:11687-95
   PubMedGoogle Scholar
• Anthonisen EH, Berven L, Holm S, et al. Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. J Biol Chem 2010;285:1607-15
   PubMedGoogle Scholar
• Ghisletti S, Huang W, Ogawa S, et al. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol Cell 2007;25:57-70
   PubMed Web of Science ®Google Scholar
• Venteclef N, Jakobsson T, Steffensen KR, et al. Metabolic nuclear receptor signaling and the inflammatory acute phase response. Trends Endocrinol Metab 2011;22:333-43
   PubMed Web of Science ®Google Scholar
• Ogawa S, Lozach J, Benner C, et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005;122:707-21
   PubMed Web of Science ®Google Scholar
• Lee JH, Park SM, Kim OS, et al. Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes. Mol Cell 2009;35:806-17
   PubMed Web of Science ®Google Scholar
• Calkin AC, Tontonoz P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nature reviews. Mol Cell Biol 2012;13:213-24
   Google Scholar
• Jakobsson T, Treuter E, Gustafsson JA, et al. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol Sci 2012;33:394-404
   PubMed Web of Science ®Google Scholar
• Kang J, Rivest S. Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors. Endocr Rev 2012;33:715-46
   PubMedGoogle Scholar
• Zhang L, Reue K, Fong LG, et al. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis. Arterioscler Thromb Vasc Biol 2012;32:2541-6
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Ranalletta M, Wang N, et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest 2007;117:3900-8
   PubMed Web of Science ®Google Scholar
• Wang X, Collins HL, Ranalletta M, et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest 2007;117:2216-24
   PubMed Web of Science ®Google Scholar
• Naik SU, Wang X, Da Silva JS, et al. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 2006;113:90-7
   PubMed Web of Science ®Google Scholar
• Repa JJ, Liang G, Ou J, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000;14:2819-30
   PubMed Web of Science ®Google Scholar
• Bradley MN, Hong C, Chen M, et al. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. J Clin Invest 2007;117:2337-46
   PubMed Web of Science ®Google Scholar
• Yasuda T, Grillot D, Billheimer JT, et al. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol 2010;30:781-6
   PubMed Web of Science ®Google Scholar
• Lo Sasso G, Murzilli S, Salvatore L, et al. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab 2010;12:187-93
   PubMed Web of Science ®Google Scholar
• Feig JE, Pineda-Torra I, Sanson M, et al. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest 2010;120:4415-24
   PubMed Web of Science ®Google Scholar
• Joseph SB, Bradley MN, Castrillo A, et al. LXR-Dependent Gene Expression Is Important for Macrophage Survival and the Innate Immune Response. Cell 2004;119:299-309
   PubMed Web of Science ®Google Scholar
• Joseph SB, Castrillo A, Laffitte BA, et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003;9:213-19
   PubMed Web of Science ®Google Scholar
• Valledor AF, Hsu LC, Ogawa S, et al. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA 2004;101:17813-18
   PubMed Web of Science ®Google Scholar
• Pascual-Garcia M, Valledor AF. Biological roles of liver X receptors in immune cells. Arch Immunol Ther Exp (Warsz) 2012;60:235-49
   PubMedGoogle Scholar
• A-Gonzalez N, Bensinger SJ, Hong C, et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 2009;31:245-58
   PubMed Web of Science ®Google Scholar
• Hong C, Kidani Y, A-Gonzalez N, et al. Coordinate regulation of neutrophil homeostasis by liver X receptors in mice. J Clin Invest 2012;122:337-47
   PubMed Web of Science ®Google Scholar
• Blaschke F, Takata Y, Caglayan E. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor. Circ Res 2006;99:e88-99
   PubMed Web of Science ®Google Scholar
• Venteclef N, Jakobsson T, Ehrlund A, et al. GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Gen Dev 2010;24:381-95
   PubMed Web of Science ®Google Scholar
• Birrell MA, Catley MC, Hardaker E, et al. Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses. J Biol Chem 2007;282:31882-90
   PubMed Web of Science ®Google Scholar
• Smoak K, Madenspacher J, Jeyaseelan S, et al. Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense. J Immunol 2008;180:3305-12
   PubMed Web of Science ®Google Scholar
• Korf H, Vander Beken S, Romano M, et al. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J Clin Invest 2009;119:1626-37
   PubMed Web of Science ®Google Scholar
• Bruhn KW, Marathe C, Maretti-Mira AC, et al. LXR deficiency confers increased protection against visceral Leishmania infection in mice. PLoS Negl Trop Dis 2010;4:e886
   PubMedGoogle Scholar
• Wang YY, Dahle MK, Steffensen KR, et al. Liver X receptor agonist GW3965 dose-dependently regulates LPSmediated liver injury and modulates post-transcriptional TNFalpha production and p38 MAPK activation in liver macrophages. Shock 2009;32:548-53
   PubMedGoogle Scholar
• Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 2012;51(Suppl 5):v3-11
   PubMed Web of Science ®Google Scholar
• Collins-Racie LA, Yang Z, Arai M, et al. Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage: reduced LXR signaling contributes to catabolic metabolism typical of osteoarthritis. Osteoarthritis Cartilage 2009;17:832-42
   PubMedGoogle Scholar
• Li N, Rivera-Bermudez MA, Zhang M, et al. LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis model. Proc Natl Acad Sci USA 2010;107:3734-9
   PubMed Web of Science ®Google Scholar
• Park MC, Kwon YJ, Chung SJ, et al. Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. Rheumatology 2010;49:882-90
   Google Scholar
• Muller-Ladner U, Kriegsmann J, Franklin BN, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15
   PubMed Web of Science ®Google Scholar
• Laragione T, Gulko PS. Liver X receptor regulates rheumatoid arthritis fibroblast-like synoviocyte invasiveness, matrix metalloproteinase 2 activation, interleukin-6 and CXCL10. Mol Med 2012;18:1009-17
   PubMed Web of Science ®Google Scholar
• Yoon CH, Kwon YJ, Lee SW, et al. Activation of liver x receptors suppresses inflammatory gene expressions and transcriptional corepressor clearance in rheumatoid arthritis fibroblast like synoviocytes. J Clin Immunol 2013;33:190-9
   PubMedGoogle Scholar
• Asquith D, Miller AM, Hueber AJ, et al. Liver X receptor agonism promotes articular inflammation in murine collagen-induced arthritis. Arthritis Rheum 2009;60:2655-65
   PubMedGoogle Scholar
• Asquith DL, Miller AM, Reilly J, et al. Simultaneous activation of the liver X receptors (LXRalpha and LXRbeta) drives murine collagen-induced arthritis disease pathology. Ann Rheum Dis 2011;70:2225-8
   PubMed Web of Science ®Google Scholar
• Asquith DL, Ballantine LE, Nijjar JS, et al. The liver X receptor pathway is highly upregulated in rheumatoid arthritis synovial macrophages and potentiates TLR-driven cytokine release. Ann Rheum Dis 2013; [Epub ahead of print]
   PubMedGoogle Scholar
• Robertson KM, Norgard M, et al. Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation. J Bone Miner Res 2006;21:1276-87
   PubMedGoogle Scholar
• Prawitt J, Beil FT, Marshall RP, et al. Short-term activation of liver X receptors inhibits osteoblasts but long-term activation does not have an impact on murine bone in vivo. Bone 2011;48:339-46
   PubMedGoogle Scholar
• Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 2007;40:251-64
   PubMed Web of Science ®Google Scholar
• Remen KM, Henning P, Lerner UH, et al. Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor kappaB ligand (RANKL)-induced osteoclast differentiation in an LXRbeta-dependent mechanism. J Biol Chem 2011;286:33084-94
   PubMedGoogle Scholar
• Kleyer A, Scholtysek C, Bottesch E, et al. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. J Bone Miner Res 2012;27:2442-51
   PubMedGoogle Scholar
• Robertson-Remen KM, Lerner UH, Gustafsson JA, et al. Activation of the liver X receptor-beta potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages. J Leukoc Biol 2013;93:71-82
   PubMedGoogle Scholar
• Robertson-Remen KM, Gustafsson JA, Andersson G. The liver X receptor promotes macrophage differentiation and suppresses osteoclast formation in mouse RAW264.7 promyelocytic leukemia cells exposed to bacterial lipopolysaccharide. Biochem Biophys Res Commun 2013;430:375-80
   PubMedGoogle Scholar
• Hardy R, Cooper MS. Bone loss in inflammatory disorders. J Endocrinol 2009;201:309-20
   PubMed Web of Science ®Google Scholar
• Kiss E, Popovic Z, Bedke J, et al. Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRalpha. Am J Pathol 2011;179:92-103
   PubMed Web of Science ®Google Scholar
• Kiss E, Kranzlin B, Wagenblabeta K, et al. Lipid droplet accumulation is associated with an increase in hyperglycemia-induced renal damage: prevention by liver X receptors. Am J Pathol 2013;182:727-41
   PubMedGoogle Scholar
• Tachibana H, Ogawa D, Matsushita Y, et al. Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy. J Am Soc Nephrol 2012;23:1835-46
   PubMed Web of Science ®Google Scholar
• Albanesi C, Pastore S. Pathobiology of chronic inflammatory skin diseases: interplay between keratinocytes and immune cells as a target for anti-inflammatory drugs. Curr Drug Metab 2010;11:210-27
   PubMed Web of Science ®Google Scholar
• Komuves LG, Schmuth M, Fowler AJ, et al. Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis. J Investi Dermatol 2002;118:25-34
   PubMed Web of Science ®Google Scholar
• Schmuth M, Elias PM, Hanley K, et al. The effect of LXR activators on AP-1 proteins in keratinocytes. J Investi Dermatol 2004;123:41-8
   PubMed Web of Science ®Google Scholar
• Fowler AJ, Sheu MY, Schmuth M, et al. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Investi Dermatol 2003;120:246-55
   PubMed Web of Science ®Google Scholar
• Kumar R, Parsad D, Kanwar A, et al. Altered levels of LXR-alpha: crucial implications in the pathogenesis of vitiligo. Exp Dermatol 2012;21:853-8
   PubMedGoogle Scholar
• Lee CS, Park M, Han J, et al. Liver X receptor activation inhibits melanogenesis through the acceleration of ERK-mediated MITF degradation. J Invest Dermatol 2013;33:1063-71
   Google Scholar
• Ballard C, Gauthier S, Corbett A, et al. Alzheimer's disease. Lancet 2011;377:1019-31
   PubMed Web of Science ®Google Scholar
• Szekely CA, Thorne JE, Zandi PP, et al. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 2004;23:159-69
   PubMed Web of Science ®Google Scholar
• Koldamova RP, Lefterov IM, Staufenbiel M, et al. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J Biol Chem 2005;280:4079-88
   PubMed Web of Science ®Google Scholar
• Zelcer N, Khanlou N, Clare R, et al. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc Natl Acad Sci USA 2007;104:10601-6
   PubMed Web of Science ®Google Scholar
• Cui W, Sun Y, Wang Z, et al. Liver X receptor activation attenuates inflammatory response and protects cholinergic neurons in APP/PS1 transgenic mice. Neuroscience 2012;210:200-10
   PubMedGoogle Scholar
• Repa JJ, Li H, Frank-Cannon TC, et al. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J Neurosci 2007;27:14470-80
   PubMed Web of Science ®Google Scholar
• Terwel D, Steffensen KR, Verghese PB, et al. Critical role of astroglial apolipoprotein E and liver X receptor-alpha expression for microglial abeta phagocytosis. J Neurosci 2011;31:7049-59
   PubMed Web of Science ®Google Scholar
• Gourraud PA, Harbo HF, Hauser SL, et al. The genetics of multiple sclerosis: an up-to-date review. Immunol Rev 2012;248:87-103
   PubMed Web of Science ®Google Scholar
• Saijo K, Crotti A, Glass CK. Nuclear receptors, inflammation, and neurodegenerative diseases. Adv Immunol 2010;106:21-59
   PubMedGoogle Scholar
• Hindinger C, Hinton DR, Kirwin SJ, et al. Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J Neurosci Res 2006;84:1225-34
   PubMed Web of Science ®Google Scholar
• Xu J, Wagoner G, Douglas JC, et al. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity. J Leukoc Biol 2009;86:401-9
   PubMed Web of Science ®Google Scholar
• Cui G, Qin X, Wu L, et al. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J Clin Invest 2011;121:658-70
   PubMed Web of Science ®Google Scholar
• Bogie JF, Timmermans S, Huynh-Thu VA, et al. Myelin-derived lipids modulate macrophage activity by liver X receptor activation. PLoS One 2012;7:e44998
   PubMed Web of Science ®Google Scholar
• Sironi L, Mitro N, Cimino M, et al. Treatment with LXR agonists after focal cerebral ischemia prevents brain damage. FEBS Lett 2008;582:3396-400
   PubMedGoogle Scholar
• Morales JR, Ballesteros I, Deniz JM, et al. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke. Circulation 2008;118:1450-9
   PubMedGoogle Scholar
• Namjoshi DR, Martin G, Donkin J, et al. The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E. PLoS One 2013;8:e53529
   Web of Science ®Google Scholar
• Cui X, Chopp M, Zacharek A, et al. The neurorestorative benefit of GW3965 treatment of stroke in mice. Stroke 2013;44:153-61
   PubMedGoogle Scholar
• Steinman RM, Granelli-Piperno A, Pope M, et al. The interaction of immunodeficiency viruses with dendritic cells. Curr Top Microbiol Immunol 2003;276:1-30
   PubMed Web of Science ®Google Scholar
• Hanley TM, Blay Puryear W, Gummuluru S, et al. PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection. PLoS Pathog 2010;6:e1000981
   PubMed Web of Science ®Google Scholar
• Morrow MP, Grant A, Mujawar Z, et al. Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol Pharmacol 2010;78:215-25
   PubMed Web of Science ®Google Scholar
• Hanley TM, Viglianti GA. Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms. J Virol 2011;85:10834-50
   PubMed Web of Science ®Google Scholar
• Dubrovsky L, Van Duyne R, Senina S, et al. Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection. Biochem Biophys Res Commun 2012;419:95-8
   PubMedGoogle Scholar
• Jiang H, Badralmaa Y, Yang J, et al. Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux. Lipids Health Dis 2012;11:69
   PubMedGoogle Scholar
• Kim K, Kim KH, Kim HH, et al. Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha. Biochem J 2008;416:219-30
   PubMedGoogle Scholar
• Na TY, Shin YK, Roh KJ, et al. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma. Hepatology 2009;49:1122-31
   PubMedGoogle Scholar
• Lima-Cabello E, Garcia-Mediavilla MV, Miquilena-Colina ME, et al. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. Clin Sci 2011;120:239-50
   PubMed Web of Science ®Google Scholar
• Garcia-Mediavilla MV, Pisonero-Vaquero S, Lima-Cabello E, et al. Liver X receptor alpha-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication. Lab Invest 2012;92:1191-202
   PubMed Web of Science ®Google Scholar
• Zeng J, Wu Y, Liao Q, et al. Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner. Antiviral Res 2012;95:245-56
   PubMed Web of Science ®Google Scholar
• Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Research 2007;2007:95103
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kanwar M, Chan PS, et al. Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients. Arch Ophthalmol 2008;126:1266-72
   PubMedGoogle Scholar
• Hazra S, Rasheed A, Bhatwadekar A, et al. Liver X receptor modulates diabetic retinopathy outcome in a mouse model of streptozotocin-induced diabetes. Diabetes 2012;61:3270-9
   PubMedGoogle Scholar
• Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007;25:267-96
   PubMed Web of Science ®Google Scholar
• Villablanca EJ, Raccosta L, Zhou D, et al. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat Med 2010;16:98-105
   PubMed Web of Science ®Google Scholar
• Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 2008;454:470-7
   PubMed Web of Science ®Google Scholar
• Hu X, Steffensen KR, Jiang ZY, et al. LXRbeta activation increases intestinal cholesterol absorption leading to an atherogenic lipoprotein profile. J Intern Med 2012;272:452-64
   PubMedGoogle Scholar
• Zhang Y, Breevoort SR, Angdisen J. Liver LXRalpha expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest 2012;122:1688-99
   PubMed Web of Science ®Google Scholar
• Yang C, McDonald JG, Patel A, et al. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem 2006;281:27816-26
   PubMed Web of Science ®Google Scholar
• Spann NJ, Garmire LX, McDonald JG, et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 2012;151:138-52
   PubMed Web of Science ®Google Scholar
• Theofilopoulos S, Wang Y, Kitambi SS, et al. Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis. Nat Chem Biol 2012;9:126-33
   PubMedGoogle Scholar
• Quinet EM, Basso MD, Halpern AR, et al. LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. J Lipid Res 2009;50:2358-70
   PubMed Web of Science ®Google Scholar
• Katz A, Udata C, Ott E, et al. Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. J Clin Pharmacol 2009;49:643-9
   PubMed Web of Science ®Google Scholar
• Sacchetti P, Sousa KM, Hall AC, et al. Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells. Cell Stem Cell 2009;5:409-19
   PubMed Web of Science ®Google Scholar
• Fan X, Kim HJ, Bouton D, et al. Expression of liver X receptor beta is essential for formation of superficial cortical layers and migration of later-born neurons. Proc Natl Acad Sci USA 2008;105:13445-50
   PubMedGoogle Scholar
• Kim HJ, Fan X, Gabbi C, et al. Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia. Proc Natl Acad Sci USA 2008;105:2094-9
   PubMed Web of Science ®Google Scholar
• Dai YB, Tan XJ, Wu WF, et al. Liver X receptor beta protects dopaminergic neurons in a mouse model of Parkinson disease. Proc Natl Acad Sci USA 2012;109:13112-17
   PubMed Web of Science ®Google Scholar
• Andersson S, Gustafsson N, Warner M, et al. Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice. Proc Natl Acad Sci USA 2005;102:3857-62
   PubMed Web of Science ®Google Scholar
• Bigini P, Steffensen KR, Ferrario A, et al. Neuropathologic and biochemical changes during disease progression in liver X receptor beta-/- mice, a model of adult neuron disease. J Neuropathol Exp Neurol 2010;69:593-605
   PubMedGoogle Scholar
• Freemantle E, Chen GG, Cruceanu C, et al. Analysis of oxysterols and cholesterol in prefrontal cortex of suicides. Int J Neuropsychopharmacol 2013; [Epub ahead of print]
   Google Scholar
• Kotokorpi P, Ellis E, Parini P, et al. Physiological differences between human and rat primary hepatocytes in response to liver X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propyl oxy]phenylacetic acid hydrochloride (GW3965). Mol Pharmacol 2007;72:947-55
   PubMedGoogle Scholar
• Azuma H, Paulk N, Ranade A, et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 2007;25:903-10
   PubMed Web of Science ®Google Scholar